Prosecution Insights
Last updated: October 25, 2026

Shenzhen Cellbri Bio-Innovation Technology Co. Ltd.

Technology areas: Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Shenzhen Cellbri Bio-Innovation Technology Co. Ltd. has 3 pending office actions in Medical Devices & Mechanical Engineering. The matters are distributed among 3 distinct examiners and 3 distinct art units, giving each pending action a separate examiner and art unit context.

AYALA DELGADO, ANTHONY is the busiest examiner, with 1 pending matter. Response strategy should therefore be organized by individual prosecution record rather than by a dominant examiner relationship.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
2
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
§102 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
33% of docket
2
Mechanical / Eng
67% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AYALA DELGADO, ANTHONY 1 79.7% +17.1%
MELARAGNO, MICHAEL 1 67.5% +11.6%
NIA, FATEMEH ESFANDIARI 1 71.5% +19.9%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19015671 QUANTITATIVE DISPENSING DEVICE AND QUANTITATIVE DISPENSING METHOD FOR BIOLOGICAL AGENTS MELARAGNO, MICHAEL —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18575837 QUANTITATIVE, STERILE AND DISPOSABLE AUTOMATIC CELL SAMPLING DEVICE AND METHOD NIA, FATEMEH ESFANDIARI 22d overdue
19023269 DUAL PUMP HARVESTING METHOD AND APPARATUS AYALA DELGADO, ANTHONY —
19015671 QUANTITATIVE DISPENSING DEVICE AND QUANTITATIVE DISPENSING METHOD FOR BIOLOGICAL AGENTS MELARAGNO, MICHAEL —

Top Art Units

Art UnitApps
3746 1
3754 1
2855 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19023269 DUAL PUMP HARVESTING METHOD AND APPARATUS AYALA DELGADO, ANTHONY 3746 §102 Non-Final OA — Pending Jan 15, 2025
19015671 QUANTITATIVE DISPENSING DEVICE AND QUANTITATIVE DISPENSING METHOD FOR BIOLOGICAL AGENTS MELARAGNO, MICHAEL 3754 §102§103 Non-Final OA — Pending Jan 10, 2025
18575837 QUANTITATIVE, STERILE AND DISPOSABLE AUTOMATIC CELL SAMPLING DEVICE AND METHOD NIA, FATEMEH ESFANDIARI 2855 §103 Final Rejection 22d overdue Pending Dec 30, 2023

Managing Shenzhen Cellbri Bio-Innovation Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Shenzhen Cellbri Bio-Innovation Technology Co. Ltd. have?

Shenzhen Cellbri Bio-Innovation Technology Co. Ltd. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Shenzhen Cellbri Bio-Innovation Technology Co. Ltd. applications?

Anthony Ayala Delgado has the most, with 1 of Shenzhen Cellbri Bio-Innovation Technology Co. Ltd.'s pending office actions.

What technology area are Shenzhen Cellbri Bio-Innovation Technology Co. Ltd.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month